Cc. Smith et al., ADVERSE DRUG-REACTIONS IN A HOSPITAL-GENERAL MEDICAL UNIT MERITING NOTIFICATION TO THE COMMITTEE ON SAFETY OF MEDICINES, British journal of clinical pharmacology, 42(4), 1996, pp. 423-429
1 We have retrospectively analysed data collected by a local adverse d
rug reactions reporting scheme in an acute hospital medical setting an
d have determined the numbers and types of reactions that would have m
erited notification as yellow card reports according to the guidelines
of the Committee on Safety of Medicines. 2 The data related to 20 695
consecutive acute general medical admissions on seven general medical
wards (140 beds) and were collected over 3 years, from April 1990 to
March 1993. 3 Over 3 years there were 1420 reports of suspected advers
e drug reactions, a rate of 68.7 per 1000 admissions. 4 If the guideli
nes for reporting issued by the Committee on Safety of Medicines had b
een strictly followed, 477 yellow cards would have been sent (23.1 per
1000 admissions). In 357 of these reports (74.8%), the reaction had c
aused admission to hospital. Only 31 of the 477 potential cards (6.5%)
involved black triangle drugs and 10 of these were for minor reaction
s. 5 Only 30 of the 477 potential yellow cards (6.3%) were known to ha
ve been sent. The majority of those reactions not reported were for dr
ug-related admissions, most of which were for well-known reactions to
established drugs. 6 We have confirmed and quantified the extent of un
der-reporting of serious suspected adverse drug reactions to the Commi
ttee on Safety of Medicines from our hospital medical unit.